FDA Approves Amgen's Humira Biosimilar
The U.S. Food and Drug Administration on Friday approved Amgen Inc.'s Amjevita, a biosimilar of AbbVie Inc.'s immunosuppressant Humira — the world's best-selling drug — for which the two companies are already...To view the full article, register now.
Already a subscriber? Click here to view full article